Synthesis and evaluation of N-acetylprolinate esters - Novel skin penetration enhancers

International Journal of Pharmaceutics

Volumn 192, Issue 2, 1999, Pages 147-158

  Tenjarla, Srini N ^a   Kasina, Ram ^a   Puranajoti, Porranee ^a   Omar, Mehboob S ^a   Harris, Wayne T ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Benazepril; Hydrocortisone; Membrane vehicle partition coefficient; N acetylprolinate esters; Penetration enhancer

Indexed keywords

BENAZEPRIL; HYDROCORTISONE; LAUROCAPRAM; PENETRATION ENHANCING AGENT; PROLINE DERIVATIVE; PROPYLENE GLYCOL; TRITIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION CHAMBER; DRUG SYNTHESIS; MODEL; MOUSE; NONHUMAN; NUDE MOUSE; PARTITION COEFFICIENT; PERMEABILITY BARRIER; PRIORITY JOURNAL; SKIN PENETRATION; SKIN PERMEABILITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; AZEPINES; BENZAZEPINES; CALORIMETRY, DIFFERENTIAL SCANNING; DIFFUSION; ESTERS; HYDROCORTISONE; MICE; MICE, INBRED HRS; PROLINE; SKIN ABSORPTION; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 0032759792     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00300-2     Document Type: Article

References (13)

1. Aungst B.J., Rogers N.J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides, and amides. Int. J. Pharm. 33:1986;225-234.
2. Cooper E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 73:1984;1153-1156.
3. Cooper E.R., Merritt E.W., Smith R.L. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 74:1985;688-689.
4. Fincher T.K., Yoo S.D., Player M.R., Sowell J.W. Sr., Michniak B.B. In vitro evaluation of a series of N-dodecanoyl-L-amino acid methyl esters as dermal penetration enhancers. J. Pharm. Sci. 85:1996;920-923.
5. Francoeur M.L., Golden G.M., Potts R.O. Oleic acid: its effects on SC in relation to (trans) dermal drug delivery. Pharm. Res. 7:1990;621.
6. Franz T.J., Tojo K., Shah K.R., Kydonieus A. Transdermal delivery. Kydonieus A. Treatise on Controlled Drug Delivery: Fundamentals, Optimization, Applications. 1991;341-345 Marcel Dekker, New York.
7. Ghosh T.K., Banga A.K. Methods of enhancement of transdermal drug delivery: part IIA, chemical penetration enhancers. Pharm. Tech. 17(4):1993;62-90.
8. Goodmann M., Barry B.W. Action of skin penetration enhancers, Azone, oleic acid, and DMSO: permeation and DSC studies. J. Pharm. Pharmacol. 38:1986;71.
9. Harris W.T., Tenjarla S.N., Holbrook J.M., Smith J., Mead C., Entrekin J. N-pentyl N-acetylprolinate. A new skin penetration enhancer. J. Pharm. Sci. 84:1995;640-642.
10. Raykar P.V., Man-Cheong Fung., Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human SC. Pharm. Res. 5(3):1988;140-150.
11. Sasaki H., Kojima M., Mori Y., Nakamura J., Shibasaki J. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin and flurbiprofen. J. Pharm. Sci. 80:1991;533-538.
12. Van Duzee B.F. Thermal analysis of human SC. J. Invest. Dermatol. 65:1975;404.
13. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Hadgraft J., Guy R.H. Transdermal Drug Delivery: Developmental Issues and Research Initiatives. 1989;198-201 Marcel Dekker, New York.